Results 151 to 160 of about 6,946 (216)

AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. [PDF]

Oncol Res
Su S, Zeng Y, Chen J, Dong X.
europepmc   +1 more source

Relative Efficacy of Conventional Monotherapies and Select Nonconventional, Over-the-Counter Products for Male Androgenetic Alopecia: A Network Meta-Analysis Study. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Talukder M.
europepmc   +1 more source

Virtual screening of drugs against multiple targets of Alzheimer's disease. [PDF]

J Alzheimers Dis
Ben Zaken K, Mesfin S, Bloch N, Samson AO.   +3 more
europepmc   +1 more source

Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control. [PDF]

RSC Adv
Wang Y, Li Z, Cheng J, Zheng T, Chen P, Deng X, Zhang PC, Liu B.   +7 more
europepmc   +1 more source

New Drugs: Dutasteride

Australian Prescriber, 2009
openaire   +1 more source

Prescription Trends of Initial Pharmacotherapy for Benign Prostatic Hyperplasia Among Treatment-Naïve Patients in South Korea: A Retrospective Analysis. [PDF]

Low Urin Tract Symptoms
Kim YH, Je NK.
europepmc   +1 more source

The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives. [PDF]

Biology (Basel)
Gupta AK, Dennis DJ, Economopoulos V, Piguet V.   +3 more
europepmc   +1 more source

Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters. [PDF]

Clin Exp Reprod Med
Kim YJ, Lee SR, Yu YD.
europepmc   +1 more source

Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases. [PDF]

Front Pharmacol
Gong Z, He J, Feng Q, Liu D, Liu S.
europepmc   +1 more source

Current considerations in prostate artery embolisation. [PDF]

CVIR Endovasc
Mark P, Brown NI, Ormiston WEL.
europepmc   +1 more source